The Role of Neutrophils in Tumor Progression and Metastasis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 1398
Special Issue Editors
Interests: chemokines; angiogenesis; metastasis
Special Issue Information
Dear Colleagues,
A growing body of evidence indicates that the interactions between neoplastic cells and inflammatory cells play an important role in tumor pathogenesis. These interactions are mediated by inflammatory cytokines and chemokines, leading to the recruitment of tumor-stromal-associated myeloid and endothelial cells that directly and indirectly promote tumor angiogenesis, progression, and metastasis. Neutrophils—the most abundant white blood cells in the circulation system—constitute a significant part of the tumor microenvironment, playing major roles in inflammation and cancer, and are highly involved in progression and metastasis. Additionally, abundant data suggest that neutrophils could be considered as emerging targets for multiple cancer types. This Special Issue will focus on the most recent advances in tumor-associated neutrophil recruitment, activation, and functions within the tumor microenvironment, regulating the progression and metastasis as well as development of TAN-targeted therapeutics.
Dr. Rakesh K. Singh
Dr. Leah M. Cook
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neutrophils
- innate immunity
- tumor
- microenvironment
- metastasis
- targeted therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
